In pancreatic cancer, we found that LGALS4 was amplified in 8% to 18% of sequenced tumors (Supplementary Fig. S1D), which in part explains the increased protein expression of gal 4 in PDAC. This evidence concerns the gene LGALS4 and pancreatic neoplasm.